Skip to content

Pain and Abdominal Breathing Exercises

Evaluation of the Postoperative Effects of Preoperative Abdominal Breathing Exercises in Laparoscopic Cholecystectomy Operations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05334160
Enrollment
70
Registered
2022-04-19
Start date
2021-11-15
Completion date
2022-05-15
Last updated
2022-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Breathing

Brief summary

Postoperative evaluation of patients who did and did not do preoperative abdominal breathing exercises.

Detailed description

The respiratory type and pattern of all patients will be recorded before gallbladder surgery. In Group P, abdominal breathing training will be given to the patients in this group. They will perform abdominal breathing for at least 5 minutes 6 times a day until surgery. In Group C,patients who are not given abdominal breathing. In the intraoperative period, 10 mg / kg paracetamol and 0.05 mg / kg morphine will be used for postoperative analgesia. After surgery, all patients will be given 10 mg/kg paracetamol every 8 hours and will be fitted with a patient-controlled analgesia (PCA) device (Tramadol HCL). PCA device bolus dose will be set to 20 mg, lock time will be set to 10 minutes and the number of buttons per hour will be set as 3.for postoperative analgesia.After surgery, NRS scores of the patients will be evaluated (in the recovery room, 1,2,6,12 and 24 hours. Preoperative anxiety, postoperative discharge time and analgesic consumption of all patients will be recorded.

Interventions

None listed

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Planned to gall bladder surgery * An American Society of Anesthesiologists score of 1,2 or 3

Exclusion criteria

* Severe cardiovascular disease * Respiratory disease * Psychiatric disease * Those who have chronic pain

Design outcomes

Primary

MeasureTime frame
Opioid consumptionDuring postoperative up to 24 hours
NRSDuring postoperative up to 24 hour

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026